Clinical Trial Update: To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Perrigo's glaucoma/ocular hypertension product to an FDA-approved comparator has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• FDA-approved comparator product for glaucoma/ocular hypertension
• Perrigo product for glaucoma/ocular hypertension

Snippet

Sponsor: Padagis LLC | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2025-04-02